Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies

Bowen, 2001, A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations, Clin Immunol, 98, 157, 10.1006/clim.2000.4947 Kalmar, 2003, Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema, Hum Mutat, 22, 498, 10.1002/humu.9202 Drouet, 2004, HAE: Mutation analysis of the C1INH gene, J Allergy Clin Immunol, 114, S66 Agostoni, 1992, Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients, Medicine, 71, 206, 10.1097/00005792-199207000-00003 Bork, 2006, Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency, Am J Gastroenterol, 101, 619, 10.1111/j.1572-0241.2006.00492.x Gompels, 2005, C1 inhibitor deficiency: consensus document, Clin Exp Immunol, 139, 379, 10.1111/j.1365-2249.2005.02726.x Bowen, 2004, Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema, J Allergy Clin Immunol, 114, 629, 10.1016/j.jaci.2004.06.043 De Serres, 2003, Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review, Transfus Apher Sci, 29, 247, 10.1016/j.transci.2003.08.006 Bork, 2005, Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema, Transfusion, 45, 1774, 10.1111/j.1537-2995.2005.00602.x Martinez-Sauger, 2002, Pharmacokinetic parameters of C1 inhibitor concentrate in 40 patients with hereditary angioedema (HAE): a prospective study, Haemophilia, 8, 574 Juers, 2004, Virus safety of current plasma-derived C1-INH: the Aventis Behring experience, J Allergy Clin Immunol, 114, S96 Bork, 2001, Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema, Arch Intern Med, 161, 714, 10.1001/archinte.161.5.714 Bork, 2001, Episodes of severe dyspnea caused by snoring-induced recurrent edema of the soft palate in hereditary angioedema, J Am Acad Dermatol, 45, 968, 10.1067/mjd.2001.117247 Bork, 2003, Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency, Arch Intern Med, 163, 1229, 10.1001/archinte.163.10.1229 Farkas, 2002, Clinical management of hereditary angio-edema in children, Pediatr Allergy Immunol, 13, 153, 10.1034/j.1399-3038.2002.01014.x Bork, 1989, Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency, J Allergy Clin Immunol, 83, 677, 10.1016/0091-6749(89)90082-1 Longhurst, 2006, Hereditary angioedema: causes, manifestations and treatment, Br J Hosp Med, 67, 654, 10.12968/hmed.2006.67.12.22439 Terpstra, 2007, Viral safety of C1-inhibitor NF, Biologicals, 35, 173, 10.1016/j.biologicals.2006.08.005 Tateishi, 2001, Scrapie removal using planova virus removal filters, Biologicals, 29, 17, 10.1006/biol.2001.0269 Agostoni, 2004, Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond, J Allergy Clin Immunol, 114, S51, 10.1016/j.jaci.2004.06.047 van Doorn, 2005, A phase I study of recombinant human C1 inhibitor in symptomatic patients with hereditary angioedema, J Allergy Clin Immunol, 116, 876, 10.1016/j.jaci.2005.05.019 Choi, 2007, Recombinant human C1-inhibitor in the treatment of acute angioedema attacks, Transfusion, 47, 1028, 10.1111/j.1537-2995.2007.01239.x Nuijens JH, Verdonk R, Resink T, et al., Open-label studies of recombinant human C1 inhibitor in patients with acute attacks of hereditary angioedema. Paper presented at: 5th C1 Inhibitor Deficiency Workshop; 31 May 2007; Budapest. Williams, 2003, DX-88 and HAE: a developmental perspective, Transfus Apher Sci, 29, 255, 10.1016/S1473-0502(03)00170-8 Lehmann, 2006, Ecallantide (Dyax/Genzyme), Curr Opin Investig Drugs, 7, 282 Levy, 2006, The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema, Expert Opin Investig Drugs, 15, 1077, 10.1517/13543784.15.9.1077 Cicardi, 2007, Established and new treatments for hereditary angioedema: an update, Mol Immunol, 44, 3858, 10.1016/j.molimm.2007.06.004 Caballero, 2006, Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema [letter], J Allergy Clin Immunol, 117, 476, 10.1016/j.jaci.2005.10.045 Beck, 2006, Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema [response], J Allergy Clin Immunol, 117, 477, 10.1016/j.jaci.2005.10.044 Icatibant, 2005, HOE 140, JE 049, JE049, 9,10, Drugs, 6, 239 Bhoola, 1992, Bioregulation of kinins: kallikreins, kininogens, and kininases, Pharmacol Rev, 44, 1 Dray, 1993, Bradykinin and inflammatory pain, Trends Neurosci, 16, 99, 10.1016/0166-2236(93)90133-7 Nussberger, 2002, Bradykinin-mediated angioedema, N Engl J Med, 347, 621, 10.1056/NEJM200208223470820 Cugno, 2003, Bradykinin and the pathophysiology of angioedema, Int Immunopharmacol, 3, 311, 10.1016/S1567-5769(02)00162-5 Han, 2002, Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor, J Clin Invest, 109, 1057, 10.1172/JCI200214211 Davis, 2006, Mechanism of angioedema in first complement component inhibitor deficiency, Immunol Allergy Clin North Am, 26, 633, 10.1016/j.iac.2006.08.003 Cockcroft, 1994, Inhibition of bradykinin-induced vasodilation in human forearm vasculature by Icatibant, a potent B2-receptor antagonist, Br J Clin Pharmacol, 38, 317, 10.1111/j.1365-2125.1994.tb04360.x Bork, 2007, Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant), J Allergy Clin Immunol, 119, 1497, 10.1016/j.jaci.2007.02.012